Attributes | Values |
---|
rdf:type
| |
rdfs:seeAlso
| |
Description
| - The representation of the molecular structure by a system (sequence) of amino acids has been used to establish quantitative structure-property/activity relationships (QSPR/QSAR) which can be used for (i) bioactivities of epitope-peptides, (ii) antibacterial potencies of polypeptides, and (iii) the binding affinity of peptides that bind to the class I major histocompatibility complex molecule HLA-A*0201. The representation of the peptide structure has been done via 1-letter abbreviations of amino acids, i.e., A (alanine), C (cysteine), D (aspartic), etc. This approach allows classifying amino acids according to their function in a biochemical process (promoters of increase or decrease of an endpoint).
- The representation of the molecular structure by a system (sequence) of amino acids has been used to establish quantitative structure-property/activity relationships (QSPR/QSAR) which can be used for (i) bioactivities of epitope-peptides, (ii) antibacterial potencies of polypeptides, and (iii) the binding affinity of peptides that bind to the class I major histocompatibility complex molecule HLA-A*0201. The representation of the peptide structure has been done via 1-letter abbreviations of amino acids, i.e., A (alanine), C (cysteine), D (aspartic), etc. This approach allows classifying amino acids according to their function in a biochemical process (promoters of increase or decrease of an endpoint). (en)
|
Title
| - QSAR modeling of endpoints for peptides which is based on representation of the molecular structure by a sequence of amino acids
- QSAR modeling of endpoints for peptides which is based on representation of the molecular structure by a sequence of amino acids (en)
|
skos:prefLabel
| - QSAR modeling of endpoints for peptides which is based on representation of the molecular structure by a sequence of amino acids
- QSAR modeling of endpoints for peptides which is based on representation of the molecular structure by a sequence of amino acids (en)
|
skos:notation
| - RIV/00064165:_____/12:13507!RIV13-MZ0-00064165
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00064165:_____/12:13507
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - QSAR; sequence of amino acids; antibacterial activity; binding affinity; CORAL software; genetic algorithm; optimization; descriptors (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Raška, Ivan jr.
- Benfenati, E.
- Gini, G.
- Toropov, A., A.
- Toropova, A., P.
|
http://linked.open...ain/vavai/riv/wos
| |
issn
| |
number of pages
| |